⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL230251 | 1.00 | — | — | |
| Alcohol SCHEMBL16679847 | 0.90 | MEN1 (0.46) | — | |
| 2-Pyridinecarboxaldehyde SCHEMBL3431231 | 0.87 | ALDH1A1 (0.47) | — | |
| Glycine SCHEMBL8213980 | 0.84 | ALDH1A1 (0.45) | — | |
| SCHEMBL9868200 | 0.84 | SMN1; SMN2 (0.41) | — | |
| SCHEMBL7527384 | 0.82 | ALDH1A1 (0.40) | — | |
| SCHEMBL303150 | 0.82 | CCR1 (0.55) | — | |
| SCHEMBL4712658 | 0.80 | RAB9A (0.76) | — | |
| SCHEMBL1957722 | 0.80 | TERT (0.38) | — | |
| SCHEMBL18773795 | 0.80 | HTT (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3723754-B1 | IMIDAZO [1,2-C] QUINAZOLIN-5-AMINE COMPOUNDS WITH A2A ANTAGONIST PROPERTIES | MERCK SHARP & DOHME LLC (US) | 2026-05-13 | — | — | EP | claimed |
| CN-120058554-A | Epoxy curing agent containing double dynamic bonds, preparation method thereof, degradable and reconfigurable epoxy resin material and preparation method thereof | 西安智聚复合材料科技有限公司 | 2025-05-30 | — | — | CN | claimed |
| EP-4584250-A1 | COMBINATION THERAPIES INCLUDING METAL CHANNEL ACTIVATORS | Biohaven Therapeutics Ltd. (VG) | 2025-07-16 | — | — | EP | disclosed |
| CN-120058554-A | Epoxy curing agent containing double dynamic bonds, preparation method thereof, degradable and reconfigurable epoxy resin material and preparation method thereof | 西安智聚复合材料科技有限公司 | 2025-05-30 | — | — | CN | disclosed |
| CN-119930711-A | Chiral ferrocene skeleton tetradentate ligand and application thereof in asymmetric hydrogenation reaction | 中国人民解放军空军军医大学 | 2025-05-06 | — | — | CN | disclosed |
| US-20250051316-A1 | 2-(ARYL-2-YL) MORPHOLINE AND DEUTERATED DERIVATIVE THEREOF, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | SHANGHAI HANSOH BIOMEDICAL CO., LTD. (CN) | 2025-02-13 | — | — | US | disclosed |
| EP-4463452-A2 | C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER | Anima Biotech Inc. (US) | 2024-11-20 | — | — | EP | disclosed |
| EP-4428128-A1 | 2-(ARYL-2-YL) MORPHOLINE AND DEUTERATED DERIVATIVE THEREOF, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | Shanghai Hansoh Biomedical Co., Ltd. (CN) | 2024-09-11 | — | — | EP | disclosed |
| CN-118475553-A | Iron-catalyzed cis-dihydroxylation of quinones with high enantioselectivity | 港大科桥有限公司 | 2024-08-09 | — | — | CN | disclosed |
| WO-2024054811-A1 | COMBINATION THERAPIES INCLUDING METAL CHANNEL ACTIVATORS | BIOHAVEN THERAPEUTICS LTD. (VG) | 2024-03-14 | — | — | WO | disclosed |
| US-20230322704-A1 | COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN | GLOBAL BLOOD THERAPEUTICS, INC. | 2023-10-12 | — | — | US | disclosed |
| WO-2023177700-A2 | C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER | ANIMA BIOTECH INC. (US) | 2023-09-21 | — | — | WO | disclosed |
| US-11718588-B2 | 5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis | GALAPAGOS NV (BE) | 2023-08-08 | — | — | US | disclosed |
| US-11530191-B2 | Compounds and uses thereof for the modulation of hemoglobin | GLOBAL BLOOD THERAPEUTICS, INC. (US) | 2022-12-20 | — | — | US | disclosed |
| US-20220340893-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2022-10-27 | — | — | US | disclosed |